- authorisedTherapeutic exploratory (Phase II)
Giving Upfront Anti-p40 to Reduce toxicity from Dual Immune Checkpoint Inhibition in MESOthelioma
This clinical trial is testing whether a medicine called Stelara can reduce severe side effects in people receiving two immunotherapy drugs for pleural mesothelioma. Pleural mesothelioma is cancer of the chest lining. Researchers want to see if adding Stelara makes treatment safer without stopping the cancer therapy from working.
Netherlands - recruiting
TRAcking Thoracic Cancer Evolution Through Therapy (Rx) EVO
This study, called TRACERx EVO, looks at how lung cancer and mesothelioma change during treatment. It involves collecting information and samples from patients with early or advanced disease to help doctors understand the illnesses better and find new ways to treat them.
United Kingdom